Related Experiment Video
Updated: Aug 12, 2026
12:33
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
[Pathophysiology solves key questions in the therapy of type 2 diabetes mellitus]
1III. interní klinika 1. lékarské fakulty UK a VFN, Praha.
Vnitrni Lekarstvi
|June 10, 2003
Abstract:
Pathophysiological mechanisms accompanying Type 2 diabetes mellitus are the basement for the rational therapy of this disease. The finding of the relationship between impaired insulin secretion and its action including the regulatory mechanisms is of importance for successful treatment. In a review article there are included the most important pathways influencing therapeutical considerations in clinical practice.
Insights
Understanding Type 2 diabetes mellitus requires examining its pathophysiology. Key insights into impaired insulin secretion and action are crucial for effective diabetes treatment strategies.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Context:
- Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder.
- Understanding the pathophysiology of T2DM is essential for effective therapeutic interventions.
- Current treatment strategies focus on managing hyperglycemia and its complications.
Purpose:
- To review the key pathophysiological mechanisms underlying Type 2 diabetes mellitus.
- To elucidate the relationship between impaired insulin secretion and insulin action.
- To highlight regulatory mechanisms influencing therapeutic considerations in clinical practice.
Summary:
- This review synthesizes critical pathophysiological pathways involved in T2DM.
- It emphasizes the interplay between insulin secretion deficits and impaired insulin sensitivity.
- The article discusses how these mechanisms inform rational therapeutic approaches.
Impact:
- Provides a foundation for developing more targeted and effective T2DM therapies.
- Aids clinicians in making informed treatment decisions based on underlying disease mechanisms.
- Contributes to advancing the understanding and management of Type 2 diabetes mellitus.
Related Concept Videos
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.